Insiders Updates

Utz Brands Inc (UTZ) receives a Buy rating from DA Davidson

Roman Campbell

Utz Brands Inc’s recent filing unveils that its 10% Owner Series R of UM Partners, LLC acquired Company’s shares for ...

Recent Insider Activity Suggests Potential Gains for Aramark (ARMK)

Anna Perez

Aramark’s recent filing unveils that its Chief Executive Officer ZILLMER JOHN J acquired Company’s shares for reported $0.25 million on ...

Wesco International, Inc (WCC) gets rating Upgrade from RBC Capital Mkts

Samantha Gray

Wesco International, Inc’s recent filing unveils that its EVP & CHRO Wolf Christine Ann unloaded Company’s shares for reported $1.22 ...

Understanding the Risks of Investing in Mineralys Therapeutics Inc (MLYS)

Daniel Torres

Mineralys Therapeutics Inc’s recent filing unveils that its Director Slingsby Brian Taylor unloaded Company’s shares for reported $43.35 million on ...

Rigetti Computing Inc [RGTI] Insider Activity: An Update for Investors

Jaxson Clark

Rigetti Computing Inc’s recent filing unveils that its Director Clifton Michael S. unloaded Company’s shares for reported $4.1 million on ...

DVAX (Dynavax Technologies Corp) may reap gains as insiders became active recently

Roman Campbell

Dynavax Technologies Corp’s recent filing unveils that its Director Myers Scott Dunseth acquired Company’s shares for reported $41116.0 on Aug ...

Investing in Annovis Bio Inc (ANVS): What You Must Know

Samantha Gray

Annovis Bio Inc’s recent filing unveils that its Director Hoffman Michael B acquired Company’s shares for reported $0.19 million on ...

JP Morgan’s latest rating for FTDR stock

Anna Perez

Frontdoor Inc’s recent filing unveils that its Former Officer Chastitie acquired Company’s shares for reported $1.38 million on Dec 10 ...

JP Morgan analysts initates a Neutral rating for Verisign Inc (VRSN)

Daniel Torres

Verisign Inc’s recent filing unveils that its Exec. Chairman, Pres, & CEO BIDZOS D JAMES unloaded Company’s shares for reported ...

Akari Therapeutics Plc ADR (AKTX) receives a Buy rating from Maxim Group

Jaxson Clark

Akari Therapeutics Plc ADR’s recent filing unveils that its CEO Gaslightwala Abizer acquired Company’s shares for reported $9400.0 on Aug ...

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.